Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study.
Jun Won ParkHyoun-Ah KimKichul ShinYong-Beom ParkTae-Hwan KimYeong Wook SongEun Young LeePublished in: Arthritis research & therapy (2019)
Mild tapering of TNFi has efficacy comparable with that of the standard-dose treatment for ASDAS-ID achievement in patients with axSpA.